On November 4, 2019, Paul V. Campanelli notified the Board of his intention to retire as Endo International plc's President and Chief Executive Officer. Consequently, the Board implemented its Chief Executive Officer succession plan. In addition Campanelli has been appointed Chairman of the Board, effective immediately.

Mr. Campanelli will continue to serve as the Company's President and Chief Executive Officer until his successor is appointed. He also expects to continue as Chairman of the Board after ceasing to serve as President and Chief Executive Officer of the Company. Roger Kimmel, who has served as Chairman of the Board, has been appointed Senior Independent Director, replacing Dr. Sharad Mansukani, M.D., CPE, CMCE.

On November 4, 2019, Dr. Mansukani, who has been a member of the Board since November 2017 and has served as the Senior Independent Director since April 2018, notified the Company of his intention to resign from the Board, effective November 4, 2019, in order to focus on his other commitments, including his recent appointment as chairman of the board of another company. There are no disagreements between Dr. Mansukani and the Company, the Company's management or Board on any matters relating to the Company's operations, policies or procedures.